October 2003
Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  
Sep   Nov


For more search options, please see the Advanced search form and the section of the User's Guide, Tips for Searching PULSE.


C H A N N E L S
PULSE Home Page
EXECUTIVE EDITION

US News
Canada News
UK News
New Zealand News

Consumer Advocacy
Health Care Systems
Managed Care/Medicaid
Co-occurring Disorders
Clinical studies
Pharmaceutical News
Criminal Justice Systems
Legislative News


U S E R ' S   G U I D E
About PULSE
PULSE Channels

Archives

Adding comments

Using the # link

Items that require registration

PULSE syndication

Tips for Searching PULSE


E M A I L   S U B S C R I P T I O N S

For WEEKLY summaries of PULSE postings, see the weekly email subscription form.

For DAILY mailings (powered by Bloglet), please enter your e-mail address below:


P U B L I C A T I O N S

PULSE ANNUAL No. 2
January 2003

Recent Trends, Challenges and Issues in Funding Public Mental Health Services in the US
March 2002

PULSE ANNUAL No. 1
October 2001

 

PULSE is powered by
Radio Userland
.

Listed on BlogShares

© Bill Davis, 2000-2003.

About PULSE | Channels | User's Guide | Email subscriptions | Publications




PULSE is a free service of the Centre for Community Change International, gathering new and noteworthy Internet resources for mental health providers, family members of individuals with mental illness, consumers of mental health services and consumer advocates. PULSE is researched, edited and designed by Bill Davis.



daily link  Thursday, October 09, 2003


Managing Psychotropic Drug Costs: Will Formularies Work?
Health Affairs article available in full text through Medscape - "In this paper Haiden Huskamp explains that in the past payers have been reluctant to restrict the choice of psychotropic drugs through the use of formularies, because these drugs play a pivotal role in treating severe mental illness and allowing patients to return to productive life. However, as the price tag for this class of drugs continues to rise, it becomes a natural target of cost containment for insurers and pharmacy benefit managers. Huskamp examines whether the use of formularies for psychotropic drugs has promise or whether it has the potential to harmpatients and reverse some of the remarkable progress in mental health treatment that is partially attributable to the broad use of these drugs." [Viewing Medscape resources requires registration, which is free].  
permalink